Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001510281-24-000511
Filing Date
2024-10-03
Accepted
2024-10-03 13:02:29
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4146
  Complete submission text file 0001510281-24-000511.txt   6207
Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174 212-542-4635
Saba Capital Management, L.P. (Reporting) CIK: 0001510281 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 811-23466 | Film No.: 241350673

Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address
Weinstein Boaz (Reporting) CIK: 0001608233 (see all company filings)

Type: 4 | Act: 34 | File No.: 811-23466 | Film No.: 241350672

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 800 882 0052
BlackRock Health Sciences Term Trust (Issuer) CIK: 0001785971 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231